Global Urgent

Global Urgent and Advanced Research and Development (GuardRX) is a non-profit biotechnology organization dedicated to the development of medical countermeasures for neglected diseases and global health emergencies. Established in 2018, the organization focuses on advancing prophylactic and therapeutic candidates that lack traditional commercial pathways, such as vaccines for Ebola and other infectious threats. GuardRX collaborates with academic institutions, government agencies like DARPA, and industry partners like INOVIO to spearhead clinical trials and build regulatory data packages. By bridging the gap between early-stage research and clinical implementation, the organization aims to ensure the availability of life-saving products for vulnerable global populations.